Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials

Name: Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials
SKU: 7259
Availability: InStock

$0.00

7-mf_suppl_gorman

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Mental Fitness Academic Supplement - VOL 7 No. 3 - Supp. 1, Mental Fitness Tags: andrew-korotzer, citalopram, efficacy, escitalopram, guojin-su, jack-m-gorman, major-depressive-disorder, mdd, placebo-controlled-trials, pooled-analysis

Description

Description

Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials

By Jack M. Gorman, MD, Andrew Korotzer, PhD, and Guojin Su, PhD

7-mf_suppl_gorman

Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials

Description

Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study

Assessing Rates and Predictors of Tachyphylaxis

Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials

John P. Houston – Early Symptom Change Prediction of Remission in Depression Treatment

Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials

Description

Related products

Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study

Assessing Rates and Predictors of Tachyphylaxis

Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials

John P. Houston – Early Symptom Change Prediction of Remission in Depression Treatment